Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
ASCP Corner
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
S. Charles Schulz, M.D.
JCP
Supplement Article
Assessing Cognitive Impairment in Patients With Schizophrenia
February 24, 2016
S. Charles Schulz
,
Aimee Murray
JCP
Supplement Article
Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia
February 24, 2016
Sophia Vinogradov
,
S. Charles Schulz
JCP
Original Research
A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study
April 5, 2011
Mary C. Zanarini
,
S. Charles Schulz
,
Holland C. Detke
, et al
JCP
Original Research
Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
June 15, 2007
René S. Kahn
,
S. Charles Schulz
,
Veselin D. Palazov
, et al
JCP
Article
Clinical Use of Quetiapine in Disease States Other Than Schizophrenia
December 31, 2002
Adityanjee
,
S. Charles Schulz
JCP
Original Research
Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients
June 30, 1999
S. Charles Schulz
,
Paul A. Thompson
,
Marc Jacobs
, et al
JCP
Article
Treatment and Outcomes in Adolescents With Schizophrenia
June 1, 1998
S. Charles Schulz
,
Robert L. Findling
,
Lee Friedman
, et al
